Clinical Trial Update: Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC) in Patients With Stable Type 2 Diabetes and Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial of IW-1973, an sGC stimulator, in stable type 2 diabetes with hypertension completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• IW-1973 (IW-1973)

Snippet

Sponsor: Cyclerion Therapeutics | Conditions: Diabetes Mellitus, Type 2, Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2020-08-31